Step off the SCOPE show floor and into something more relaxed. Join Florence for an invite-only evening with pharma, biotech, and site leaders who are shaping what clinical trials look like next.

We’ll have cocktails, light bites, and the kind of conversations that don’t happen in conference hallways — plus a sneak peek at Florence’s 2026 State of the Industry research on what it really takes to run trials with intelligence (and momentum).

We’re not afraid to go fast. Get an Uber on us — from wherever you are in Orlando*. We’ll get you to the after-party first class, so you can skip the logistics and just enjoy the night.

Your hosts are some of the biggest names in clinical trial innovation today. Both Catherine Gregor and Ryan Jones will be on-hand to offer a preview of the data-driven insights shaping 2026 strategy, showing:

• 4x improvement on startup activity time for sites that have used Florence
• Strategic advantages of operating with intelligence across 65,000+ study sites
• Early risk detection capabilities that protect timelines and budgets

Plus, Jim Wagner of TCN will be there to show you how his team is breaking barriers by incorporating AI-powered contracting flows into clinical trial operations.

You’ll be joined in conversion by senior executives from pharmaceutical, biotech, site networks, and site operators: your peers who are driving digital transformation and operational excellence in clinical trials.

These are the colleagues that will inspire you to grow and learn. The people who ask “what if we tried something different?” and then actually do it.  

* Limited to the first 50 qualified attendees of SCOPE